Evidence map›Paper›PMID 20059482›Full record

ArticleClinical and experimental immunology2010

Sequential expression of macrophage anti-microbial/inflammatory and wound healing markers following innate, alternative and classical activation.

F M Menzies, F L Henriquez, J Alexander, C W Roberts

Abstract read
In one paragraph

Article in Clinical and experimental immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. 15-FAntioxidants (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Dynamics of the Skin's Immune System.International journal of molecular sciences · 2019
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Imaging Reporter Strategy to Monitor Gene Activation of Microglia Polarisation States under Stimulation.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

F M MenziesStrathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK.
F L Henriquez
J Alexander
C W Roberts

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study examines the temporal dynamics of macrophage activation marker expression in response to variations in stimulation. We demonstrate that markers can be categorized as 'early' (expressed most abundantly at 6 h post-stimulation) or 'late' (expressed at 24 h post-stimulation). Thus nos2 and p40 (IL-12/IL-23) are early markers of innate and classical activation, while dectin-1 and mrc-1 are early markers and fizz1 (found in inflammatory zone-1) and ym1 are late markers of alternative activation. Furthermore, argI is a late marker of both innate and alternative activation. The ability of interferon (IFN)-gamma to alter these activation markers was studied at both the protein level and gene level. As reported previously, IFN-gamma was able to drive macrophages towards the classical phenotype by enhancing nos2 gene expression and enzyme activity and p40 (IL-12/IL-23) gene expression in lipopolysaccharide (LPS)-stimulated macrophages. IFN-gamma antagonized alternative macrophage activation, as evident by reduced expression of dectin-1, mrc-1, fizz1 and ym1 mRNA transcripts. In addition, IFN-gamma antagonized arginase activity irrespective of whether macrophages were activated innately or alternatively. Our data explain some apparent contradictions in the literature, demonstrate temporal plasticity in macrophage activation states and define for the first time 'early' and 'late' markers associated with anti-microbial/inflammatory and wound healing responses, respectively.

Indexed as

AnimalsAntiviral AgentsArginasebeta-N-AcetylhexosaminidasesBiomarkersDectin-1Gene Expression RegulationImmunity, InnateInflammation MediatorsIntercellular Signaling Peptides and ProteinsInterferon-gammaInterleukin-12 Subunit p40LectinsLectins, C-TypeMacrophage ActivationMacrophagesAntiviral AgentsArg1 protein, mouseArginasebeta-N-AcetylhexosaminidasesBiomarkersChil3 protein, mouseDectin-1Inflammation MediatorsIntercellular Signaling Peptides and ProteinsInterferon-gammaInterleukin-12 Subunit p40LectinsLectins, C-TypeMembrane ProteinsNerve Tissue ProteinsNitric Oxide Synthase Type IINos2 protein, mouseRetnla protein, mouse

Identifiers

PMID20059482
PMCPMC2883107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.